Zenpep

Quick links to important sections

Zenpep

Selected form

Method of action: Enzymes

Treatment option: Cystic Fibrosis

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zenpep

Zenpep: What It Is

Property Description
Active ingredient Pancrelipase (Lipase, Protease, Amylase)
Form Delayed-release capsules (oral)
Pharmacological class Pancreatic Enzyme Replacement Therapy (PERT)
Common use Supplementation to aid digestion
Origin Biologic (Porcine-derived)

Zenpep is a prescription-only medication that is formally classified as a Pancreatic Enzyme Replacement Therapy (PERT), which places it within the class of digestive aids used for enzyme supplementation. The drug’s necessity is clinically recognized for patients who require assistance breaking down food due to insufficient natural enzyme production. The medication's essential purpose is to help the body process food when pancreatic function is compromised.


Active Composition and Biologic Origin

The core active ingredient, Pancrelipase, is a combination product of three major pancreatic enzymes: lipase, protease, and amylase. This complete enzymatic blend is derived from porcine (pig) pancreatic glands, confirming its biologic origin.

This formulation is designed to provide comprehensive digestion support. Lipase facilitates the hydrolysis of fats, protease manages the breakdown of proteins, and amylase drives the breakdown of starches. This standardization ensures that the medication offers a consistent level of catalytic action, supporting the patient’s ability to efficiently assimilate all key macronutrients.


Oral Formulation: Targeted Delivery

Zenpep is an oral formulation delivered via delayed-release capsules that contain numerous enteric-coated microspheres. This specific drug form is engineered for targeted delivery. The specialized coating prevents the powerful pancreatic enzymes from being destroyed by the high acidity of the stomach. This protective mechanism ensures the enzymes remain intact and are released only upon reaching the small intestine, maximizing their therapeutic efficacy for digestion where it is needed most.

Regulatory References

  1. Pancrelipase: MedlinePlus Drug Information

What side effects are possible with Zenpep?

Possible Side Effects and Safety Information

Zenpep (pancrelipase) is a pancreatic enzyme product used to treat exocrine pancreatic insufficiency (EPI). The safety profile is defined by officially documented adverse reactions and specific warnings.

Adverse Reactions

The most commonly reported adverse reactions in clinical trials (occurring in ge 6% of patients) included headache, contusion (bruising), cough, and early satiety. Other common reactions (occurring in 1% to 10%) involved the gastrointestinal system (e.g., abdominal pain, flatulence, diarrhea, nausea) and the skin (e.g., rash, pruritus).

Serious and Clinically Significant Safety Information

Fibrosing Colonopathy: A rare, serious disorder of the large intestine, characterized by colonic strictures, has been associated with high-dose use of pancreatic enzyme products, particularly in pediatric patients with cystic fibrosis. Caution is required when daily doses exceed 10,000 lipase units/kg of body weight.

Hypersensitivity: Severe allergic reactions, including anaphylaxis, can occur due to the product’s porcine (pork) protein content. Zenpep is contraindicated in patients with a known allergy to pork protein.

Hyperuricemia: The product contains purines, which can increase blood uric acid levels, potentially leading to or exacerbating gout or renal impairment. Monitoring may be advised, especially at higher doses.

Risk of Oral Irritation: The delayed-release capsules or their contents should not be crushed or chewed to avoid irritating or ulcerating the oral mucosa by destroying the protective enteric coating. The theoretical risk of viral transmission from the porcine source material cannot be excluded, though steps are taken to minimize this risk.

Overdose and Emergency Response

Overdose and when to Seek Help

Overdose with pancrelipase is defined by officially documented clinical and metabolic manifestations associated with excessive intake, as stated in regulatory labeling. The ingestion of high dosages is linked to serious gastrointestinal outcomes, notably Fibrosing Colonopathy, which is classified as a severe bowel disorder. A consequence of this disorder, Colonic Stricture, has been specifically reported in pediatric patients with cystic fibrosis when dosages exceed regulatory thresholds, such as 6,000 lipase units/kg/meal.

Furthermore, high-dose exposure may lead to Hyperuricemia, which is an officially documented metabolic abnormality involving elevated blood uric acid levels. If patient dosing exceeds 2,500 lipase units/kg/meal, further medical investigation is formally warranted, and monitoring for the progression of a pre-existing bowel disorder may be required.

Regulatory authorities mandate immediate action in cases of suspected overdose: it is required to seek emergency medical attention or to call the Poison Help line. Urgent consultation is also mandated if unusual or severe symptoms such as severe abdominal pain, vomiting, or trouble passing stool develop. The management of overdose is symptomatic and supportive, as the official labeling states that no specific antidote is known.

Therapeutic Uses of Zenpep

What Zenpep Treats: Main Uses and Benefits

Zenpep is generally used as a replacement therapy to assist patients whose bodies may be unable to produce sufficient digestive enzymes, a condition known as Exocrine Pancreatic Insufficiency (EPI). This medication is applied in clinical settings that involve acute or unstable symptom patterns associated with this deficiency.


Relief and Therapeutic Scope

The therapy is commonly used to help manage EPI resulting from chronic conditions like Cystic Fibrosis, Chronic Pancreatitis, or following major pancreatic surgery. It helps address symptom clusters that may become intense or disruptive due to maldigestion, specifically managing manifestations such as steatorrhea (fatty, frequent stools), abdominal pain, chronic bloating, and excessive flatulence. This supportive symptomatic management assists with maintaining functional stability.

“This therapy is relevant for providing supportive digestive assistance, contributing to easing the overall symptom load when a patient’s natural enzyme production is compromised.”

The therapy may also assist with improving nutrient absorption, contributing to the assimilation of dietary fats, proteins, and carbohydrates. This generally helps counteract the systemic consequences of malabsorption, such as unexplained weight loss and nutritional deficiencies, thereby contributing to improved overall health and supporting proper growth in pediatric patients.

Quick Fact: Relief for Severe Malabsorption
The medication is relevant for easing symptoms that create noticeable physiological strain, particularly those caused by the poor digestion of dietary fats.

Regulatory References

  1. NIH MedlinePlus overview on Pancrelipase

Eligibility and Restrictions for Use

Who Can and Cannot Use Zenpep?

Zenpep is officially approved for the treatment of Exocrine Pancreatic Insufficiency (EPI) in patients across all age groups. This includes adult and pediatric patients, ranging from infants to older adults.


Absolute Contraindication

The single primary exclusion strictly defined by regulatory labeling is a known hypersensitivity or allergy to pork protein or to any component of the Zenpep formulation. Since the medication is derived from porcine pancreatic glands, this allergy constitutes an absolute prohibition.


Conditional Use and Restrictions

Certain populations require use with caution and medical monitoring, as specified in the official warnings:

  • Patients with gout, hyperuricemia, or renal impairment should be monitored due to the purine content of pancreatic enzyme products.
  • Caution is necessary for patients with a history of fibrosing colonopathy or intestinal blockage.
  • Pediatric patients with Cystic Fibrosis on high doses require specific monitoring.

Regarding pregnancy and lactation, official labeling states that it is not known if Zenpep can cause fetal harm or if the medication passes into breast milk.

What should I know about interactions with other medicines?

Zenpep (pancrelipase) is an enzyme preparation that acts locally within the digestive tract and is not absorbed into the bloodstream in significant amounts. Therefore, the product has a limited profile of known drug-drug interactions. Formal drug interaction studies have not been conducted with Zenpep.

The primary documented interaction concerns certain mineral and vitamin supplements. Exogenous pancreatic enzymes, such as those in Zenpep, may interfere with the body's ability to absorb iron and folic acid (folate) from the gastrointestinal tract. This potential interference could lead to a reduced therapeutic effect of iron or folate supplements if they are taken concurrently.

Patients who are receiving therapeutic doses of iron or folate to treat or prevent deficiencies should be monitored by their healthcare professional. This monitoring is to check for a potentially reduced hematologic response, such as a lack of expected improvement in blood counts, if the supplements and Zenpep are administered at the same time. While specific timing guidelines are not stated in the official labeling, separating the dosing of these supplements from the enzyme product may be considered to help mitigate the risk of reduced absorption.

Mechanism of Action

️ pH-Dependent Enzyme Delivery and Activation

This initial mechanistic domain describes the prerequisite for the drug's activity: the enteric-coated formulation protects the φ-sensitive enzymes from being denatured by gastric acid. This functional design facilitates the release of enzymes intended to be active only when they reach the duodenum/jejunum, where the φ is optimal for the catalytic mechanism to begin.

Localized Catalytic Hydrolysis of Macronutrients

Zenpep acts via the Lipase, Protease, and Amylase components, which function as biological catalysts by cleaving the chemical bonds in their specific dietary macromolecule substrates (fats, proteins, and carbohydrates). This localized catalytic hydrolysis provides the exogenous catalytic function necessary to break down food, generating absorbable products like free fatty acids and amino acids.

Synergistic Action and Increased Nutrient Assimilation

The mechanism involves the synergistic activity of all three enzymes working concurrently on the different food groups, which allows the catalytic action to encompass all major macronutrient substrates, replicating the breadth of natural pancreatic secretion. This coordinated breakdown leads to an increase in the Coefficient of Fat and Nitrogen Absorption (CFA/CNA), resulting in an elevated rate of nutrient assimilation.

Dosage and Administration Information

How Zenpep is Used

Zenpep is an oral medication administered strictly as a food-dependent therapy for long-term use. Its application is governed by specific instructions which dictate how the enzymatic contents must be timed and protected during consumption to ensure proper delivery.


Official Administration Guidelines

Category Usage Principle
Route of Administration Zenpep is administered by mouth (oral) using delayed-release capsules.
Dosing Schedule The dose is highly individualized and determined by the patient's body weight, clinical symptoms, and the fat content of their diet. The initial dosage for adults is 500 lipase units/kg/meal.
Timing with Food The medication must be taken during every meal and every snack to coincide with the intake of food.

Procedural Administration Rules

Proper use requires strict adherence to preparation rules to maintain the integrity of the enteric coating.

  • Handling: The capsules must be swallowed whole with sufficient liquids to ensure complete swallowing.
  • Manipulation Ban: The capsules or their contents (microspheres) must not be crushed or chewed, as this risks disrupting the acid-protective coating required for release in the small intestine.
  • Alternative Intake: For patients unable to swallow the capsule, the contents may be carefully sprinkled onto a small amount of acidic soft food (such as applesauce) and consumed immediately.

Population and Missed Dose Guidance

Administration rules include specific guidance for pediatric use and handling missed timing.

  • Pediatric Dosing: Dosage begins at 1,000 lipase units/kg/meal for children aged one to four years, and a fixed dose of 3,000 lipase units applies per 120 mL of formula or per breast-feeding for infants.
  • Missed Dose: If a dose is missed, patients should administer the next dose with the next meal or snack and not make up the skipped dose.

Recent Clinical Evidence

Research Evidence: Zenpep

The efficacy and safety of Zenpep (pancrelipase) have been established through controlled clinical trials involving adult and pediatric patients diagnosed with Exocrine Pancreatic Insufficiency (EPI), primarily due to cystic fibrosis (CF) or chronic pancreatitis.


Efficacy Outcomes

The primary measure of efficacy in the pivotal trials was the Coefficient of Fat Absorption (CFA), which assesses the body's ability to digest and absorb dietary fat. These trials were randomized, double-blind, and placebo-controlled.

  • Fat Absorption: In one primary study focusing on patients with EPI due to CF, treatment with Zenpep resulted in a significantly higher mean CFA compared to placebo. Improved fat absorption is associated with better nutritional status and reduced symptoms of fat malabsorption, such as steatorrhea.
  • Nutrient Absorption: Research also examined the effect on the absorption of fat-soluble vitamins, such as Vitamin A and Vitamin E, which showed improvement compared to the placebo group.

Safety Profile and Adverse Events

Clinical studies have generally shown the adverse events profile for Zenpep to be consistent across pediatric and adult populations. The most common adverse events reported in these trials (occurring in geq6% of patients) were typically gastrointestinal, including abdominal pain, flatulence, and headache.

Long-Term Considerations

Long-term follow-up studies have confirmed that the types and incidence of adverse events during extended use remain consistent with those observed in the initial short-term, placebo-controlled trials. Caution is typically exercised when considering higher dosages, as high-dose use of pancreatic enzyme replacement products has been associated with a rare but serious intestinal complication known as fibrosing colonopathy.

Frequently Asked Questions (FAQ)

Common questions about Zenpep (FAQ)


Q: What is Zenpep the same as Creon or other pancreatic enzyme products (PEPs)?

Zenpep is a brand-name Pancrelipase product, which belongs to the class of medications called Pancreatic Enzyme Replacement Therapy (PERT). While other PERT products exist, official information indicates that they are not interchangeable; the doses, strengths, and inactive ingredients may vary between brand names.


Q: Can children take Zenpep?

Yes, Zenpep is officially indicated and approved for treating exocrine pancreatic insufficiency (EPI) in both adult and pediatric patients, including infants. Specific dosage information for pediatric age groups is available in the official prescribing information.


Q: What's the difference between Zenpep and generic pancrelipase?

Zenpep is a brand-name formulation of the active ingredient pancrelipase. Currently, there is no generic equivalent of Zenpep available that is approved as therapeutically interchangeable. Official information notes that brand-name pancrelipase products are generally not considered interchangeable.


Q: Does Zenpep need to be refrigerated or how should it be stored?

Zenpep must be stored at room temperature and must not be refrigerated. Official guidance requires that the medication be kept in its original container, tightly closed, with the desiccant packet to protect it from moisture.


Q: Is Zenpep safe to take during pregnancy?

The official product information states that it is not known whether Zenpep can cause harm to an unborn baby or affect reproductive capacity. Zenpep is generally administered during pregnancy only after a healthcare professional determines that the potential benefit justifies the potential risk.


Q: Can Zenpep interact with vitamins or mineral supplements?

Yes, regulatory documents indicate that pancreatic enzyme products like Zenpep may interfere with the body's ability to absorb certain nutrients. Specifically, they may reduce the absorption of iron and folic acid (folate) from the gastrointestinal tract.


Q: Are there any foods or drinks that should be avoided when taking Zenpep?

The capsules or contents should not be mixed with formula or breast milk. If the capsule contents are sprinkled, regulatory guidance states they must be mixed with a small amount of an acidic soft food (such as applesauce) and taken right away. Failure to use acidic food can lead to the enzymes being destroyed by stomach acid.


Q: What are the signs that Zenpep might not be working for me?

Clinical studies measure effectiveness by looking for improvement in fat absorption and a reduction in symptoms like steatorrhea (oily, bulky stools). If symptoms of malabsorption, such as chronic diarrhea or steatorrhea, persist or worsen, this may suggest that the current therapy is not achieving the desired clinical effect.


Q: Can Zenpep be taken at the same time as thyroid medication?

Official information states that formal drug interaction studies have not been conducted with Zenpep. The product has a limited known interaction profile, specifically noting interference with iron and folic acid absorption.


Q: Does Zenpep affect blood sugar levels?

Although it is not listed as a common side effect in the main clinical trials, official post-marketing reports indicate that changes in blood glucose levels have been reported with the use of pancrelipase products.


Q: What types of fats does Zenpep help break down?

Zenpep contains the enzyme Lipase, which acts as a biological catalyst to break down dietary fats (lipids) into smaller, absorbable components. This action is necessary for the efficient assimilation of fats from food in the small intestine.


Q: Does taking Zenpep require regular blood tests or monitoring?

Regulatory labeling indicates that monitoring of blood uric acid levels may be warranted for patients with pre-existing conditions like gout, hyperuricemia, or renal impairment, particularly when higher doses are used.


Q: Can Zenpep help with unexplained weight loss?

Exocrine pancreatic insufficiency (EPI) often causes weight loss because the body cannot absorb necessary nutrients from food. By improving the digestion and absorption of dietary fats and nutrients, Zenpep works to address the malabsorption that can cause weight loss and poor nutritional status in patients with EPI.


Q: Are there specific instructions for administering Zenpep to infants?

Yes, regulatory information includes specific preparation and administration guidance for infants. The capsule contents are often mixed with a small amount of acidic soft food or administered according to detailed instructions provided in the official label.


Q: Does Zenpep affect the absorption of birth control pills?

Official drug interaction studies have not been conducted for Zenpep. The known interaction profile is limited, primarily affecting the absorption of iron and folic acid. There is no specific information about its effect on birth control pills.


Q: Is it common to see undigested food in stool while taking Zenpep?

Seeing undigested food in stool, known clinically as steatorrhea, is a key symptom of the condition Zenpep is prescribed to treat (EPI). The purpose of the medication is to reduce these symptoms by improving fat digestion. If steatorrhea persists, it may suggest that the current therapeutic regimen requires review.


Q: Is there any research on Zenpep's effectiveness in people with pancreatic cancer?

Zenpep is approved to treat exocrine pancreatic insufficiency (EPI), which may be caused by various underlying diseases. The pivotal clinical trials used to establish its effectiveness focused primarily on patients with EPI due to cystic fibrosis or chronic pancreatitis, not specifically pancreatic cancer.


Q: What is the shelf life of Zenpep once the bottle is opened?

The regulatory label specifies that the bottle must be kept tightly closed after opening to protect the medicine from moisture and maintain its effectiveness. However, the label does not specify a separate 'discard after opening' date or shelf life for the medication.

How should Zenpep be stored and disposed of?

Official Storage and Disposal Requirements

Zenpep (pancrelipase) must be stored strictly according to the following regulatory requirements to maintain product stability and integrity:

Storage Category Requirement
Temperature Store at room temperature (68 F to 77 F or 20 C to 25 C). Do not refrigerate or expose to excessive heat.
Packaging Keep the medication in the original container, tightly closed, with the desiccant packet inside to protect from moisture.
Handling Contents of the capsule must not be crushed, chewed, or inhaled. Always keep this medication out of sight and reach of children.
Stability/Disposal The contents of an opened capsule or any mixture with food must be taken immediately. Any unused capsule contents or mixtures must be discarded; do not save for later use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zenpep found in:

A-Z Index: